Cedara Receives 2004 Fastest Growing Company of the Year Award from Frost and Sullivan
10 Noviembre 2004 - 8:28AM
PR Newswire (US)
Cedara Receives 2004 Fastest Growing Company of the Year Award from
Frost and Sullivan FLORIDA, Nov. 10 /PRNewswire-FirstCall/ --
Cedara Software Corp. (NASDAQ:CDSW/TSX:CDE) a leading independent
developer of medical software technologies for the global
healthcare market, announced that Frost and Sullivan, America's
foremost market research and consulting firm, has voted Cedara the
recipient of its 2004 Fastest Growing Company of the Year Award.
Frost and Sullivan formally presented the prestigious award to
Cedara last night, at its 2004 Global Excellence in the Healthcare
and Life Sciences Awards Banquet in Florida. Frost and Sullivan is
a leading market consulting and research organization that monitors
new technologies, tracks changes in distribution channels,
forecasts market trends, and performs strategic analysis of
competitors in the healthcare industry. Each year Frost and
Sullivan recognizes outstanding industry achievements by presenting
Frost & Sullivan Awards to top companies in regional and global
markets. Its industry experts recognize the diligence and
innovation required to implement a successful business plan and
excel in the increasingly competitive global marketplace. "Cedara
is honored to be the recipient of the highly esteemed Frost and
Sullivan Fastest Growing Company of the Year Award, and to be
recognized by an industry analyst of such exceptional caliber,"
said Abe Schwartz, Cedara President and CEO. "We have been
following Cedara for many years and have been quite excited by
their recent performance within the healthcare industry. They have
grown from being a small niche competitor to one that offers a
breadth of valuable medical software solutions to a diverse group
of global healthcare clients. Their focus on cutting edge
technologies in conjunction with flexible solutions has allowed
them to make tremendous strides within the industry," says Monali
Patel, Frost and Sullivan Research Manager, Medical Imaging.
"Having our business model validated by a top industry analyst is a
powerful endorsement of how successful Cedara is with its strategy
of offering diversified, end-to-end products and services," said
Jacques Cornet, Cedara Vice President of Marketing and Operations.
About Cedara Software: Cedara Software Corp. is a leading
independent provider of medical technologies for many of the
world's leading medical device and healthcare information
technology companies. Cedara software is deployed in hospitals and
clinics worldwide - approximately 28,000 medical imaging systems
and 6,400 Picture Archiving and Communications System (PACS)
workstations have been licensed to date. Cedara is enabling the
future of the healthcare industry with new innovative approaches to
workflow, data and image management, integration, the web, software
components and professional services. The Company's medical imaging
solutions are used in all aspects of clinical workflow including
the capture of patient digital images; the sharing and archiving of
images; sophisticated tools to analyze and manipulate images; and
even the use of imaging in surgery. Cedara is unique in that it has
expertise and technologies that span all the major digital imaging
modalities including angiography, computed tomography (CT),
echo-cardiology, digital X-ray, fluoroscopy, mammography, magnetic
resonance imaging (MRI), nuclear medicine, positron emission
tomography (PET) and ultrasound. Certain statements contained in
this news release are forward-looking within the meaning of
securities laws and are based on current expectations that are
subject to a number of assumptions, uncertainties and risks, and
there are actual results may differ materially from what is
currently expected. These assumptions, uncertainties and risks
include, but are not limited to: the management of the growth of
the Company, dependence on key personnel of the Company,
competitive pressures (including price competition), changes in
market activity, risks associated with international operations,
the development of new products and services, the enhancement of
existing products and services, the introduction of competing
products having technological and/or other advantages, the
dependence on key customers, regulatory changes to the health care
industry, seasonality, economic and political conditions and
adequate protection of the proprietary interests of the Company.
Further information about these risks and uncertainties can be
found in the continuous disclosure documents filed from time to
time by Cedara with the securities regulatory authorities, which
documents are available at http://www.sedar.com/. All trademarks
appearing in this release are the property of Cedara Software Corp.
DATASOURCE: Cedara Software Corp. CONTACT: For more information
about Cedara and its products and services, visit the Cedara
website at http://www.cedara.com/ or contact: Michelle Pommells,
Cedara Software Corp., (905) 672-2100 ext. 2356, Email: .; For
investor-related inquiries, contact: Brian Pedlar, Chief Financial
Officer, (905) 672-2100 ext. 2015, Email: ; To request a free copy
of this organization's annual report, please go to
http://www.newswire.ca/ and click on reports@cnw.
Copyright